Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry
- PMID: 20525192
- PMCID: PMC2893120
- DOI: 10.1186/1475-2840-9-22
Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry
Abstract
Background: In patients hospitalized for myocardial infarction, there are limited data examining the long-term prognostic effect of diabetes. The aim of this study was to systematically evaluate the development of diabetes as an independent long-term prognostic factor after myocardial infarction.
Methods: Prospective follow-up of 6676 consecutive MI patients screened for entry in the Trandolapril Cardiac Evaluation (TRACE) study. The patients were analysed by Kaplan-Meier survival analysis, landmark analysis and Cox proportional hazard models and outcome measure was all-cause mortality.
Results: The mortality in patients with diabetes was 82,7% at 10 years of follow-up and 91,1% at 15 years of follow-up, while patients without diabetes had a mortality of 60,2% at 10 years of follow-up and 72,9% at 15 years of follow-up (p < 0.0001). Landmark analysis continued to show prognostic significance of diabetes throughout the duration of follow-up. Multivariable Cox proportional-hazards model showed that the hazard ratio for death in patients with diabetes overall was 1.47 (95% confidence intervals (CI) 1.35-1.61) and varied between 1.19 (CI 1.04-1.37) and 2.13 (CI 1.33-3.42) in the 2-year periods of follow-up.
Conclusions: Diabetes is an important independent long-term prognostic factor after MI and continues to predict mortality even 17 years after index MI. This underscores the importance of aggressive diagnostic and therapeutic approach in diabetes patients with MI.
Figures



Similar articles
-
Renal function at the time of a myocardial infarction maintains prognostic value for more than 10 years.BMC Cardiovasc Disord. 2011 Jun 27;11:37. doi: 10.1186/1471-2261-11-37. BMC Cardiovasc Disord. 2011. PMID: 21708030 Free PMC article.
-
Long-term survival after acute myocardial infarction and relation to type 2 diabetes and other risk factors.Clin Cardiol. 2010 Jul;33(7):424-9. doi: 10.1002/clc.20776. Clin Cardiol. 2010. PMID: 20641120 Free PMC article.
-
Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.Eur Heart J. 1999 Jul;20(13):973-8. doi: 10.1053/euhj.1999.1530. Eur Heart J. 1999. PMID: 10361050
-
The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.Eur Heart J. 2005 Jan;26(2):145-52. doi: 10.1093/eurheartj/ehi021. Epub 2004 Dec 8. Eur Heart J. 2005. PMID: 15618070 Clinical Trial.
-
Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarction.Eur J Prev Cardiol. 2015 Nov;22(11):1419-26. doi: 10.1177/2047487314557963. Epub 2014 Nov 11. Eur J Prev Cardiol. 2015. PMID: 25389071
Cited by
-
Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006.Cardiovasc Diabetol. 2011 Jan 19;10:5. doi: 10.1186/1475-2840-10-5. Cardiovasc Diabetol. 2011. PMID: 21247456 Free PMC article.
-
Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis.Cardiovasc Diabetol. 2011 Nov 10;10:98. doi: 10.1186/1475-2840-10-98. Cardiovasc Diabetol. 2011. PMID: 22074110 Free PMC article.
-
Mortality in patients with myocardial infarction and potential risk factors: A five-year data analysis.ARYA Atheroscler. 2022 May;18(3):1-8. doi: 10.48305/arya.v18i0.2427. ARYA Atheroscler. 2022. PMID: 36815954 Free PMC article.
-
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus.Cardiovasc Diabetol. 2010 Sep 15;9:52. doi: 10.1186/1475-2840-9-52. Cardiovasc Diabetol. 2010. PMID: 20843304 Free PMC article.
-
Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.Cardiovasc Diabetol. 2011 Jan 7;10:1. doi: 10.1186/1475-2840-10-1. Cardiovasc Diabetol. 2011. PMID: 21214916 Free PMC article.
References
-
- Bartnik M, Malmberg K, Hamsten A, Efendic S, Norhammar A, Silveira A, Tenerz A, Ohrvik J, Ryden L. Abnormal glucose tolerance--a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. J Intern Med. 2004;256(4):288–297. doi: 10.1111/j.1365-2796.2004.01371.x. - DOI - PubMed
-
- Janszky I, Hallqvist J, Ljung R, Ahlbom A, Hammar N. Prognostic role of the glucometabolic status assessed in a metabolically stable phase after a first acute myocardial infarction: the SHEEP study. J Intern Med. 2008. - PubMed
-
- Melchior T, Kober L, Madsen CR, Seibaek M, Jensen GV, Hildebrandt P, Torp-Pedersen C. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. European heart journal. 1999;20(13):973–978. doi: 10.1053/euhj.1999.1530. - DOI - PubMed
-
- Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ, Hansen ML, Folke F, Buch P, Madsen M. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117(15):1945–1954. doi: 10.1161/CIRCULATIONAHA.107.720847. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical